Oxurion NV

—As of Sun 8 Nov 2026, 12:00 UTC

EBR:OXURHealthcare

Country Belgium

PE (Fwd) •••

TSR 10Y CAGR (82.35%)

Div yield —

ROE —

Biotechnology

Beta (5Y) 0.12

PE TTM —

TSR TTM (93.85%)

Mkt cap €0.113M

ROIC —

SE Grade™

Value

Quality

Moat

Consensus

Reference

€0.0008

4.29%

(69.63%)

Hold 1|5|1|4|2

TTM

FYE 31 Dec EUR

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

5Y

10Y

Peers

—

Revenue€M

0.020

0.021

0.021

0.021

0.022

0.023

0.024

0.025

0.026

0.027

—

4.04%

3.01%

86

23.58

Revenue growth%

21.25

18.67

18.22

18.12

19.73

19.61

18.00

18.50

21.46

21.83

13.62

19.61

19.14

40

8.42

Gross margin%

21.88

23.27

24.10

22.79

20.52

18.97

16.04

14.08

11.69

12.39

7.94

14.08

19.75

95

22.72

Operating margin%

12.85

12.01

10.29

12.19

12.96

11.16

13.80

13.58

12.23

11.75

19.58

12.23

12.21

24

27.57

Net margin%

31.31

33.08

35.44

35.28

34.09

32.60

33.68

32.62

32.64

32.10

18.91

32.62

32.86

75

19.22

P/E ratio (avg)x

22.98

22.71

19.87

21.23

22.89

24.36

24.62

23.02

23.33

21.20

27.58

23.33

22.93

43

25.26

EV/EBITx

32.97

31.94

36.87

34.85

39.08

36.33

33.80

36.78

35.62

41.45

32.26

36.33

35.98

83

17.76

FCF yield (avg)%

30.02

31.78

29.70

27.69

27.22

26.04

26.92

27.12

24.16

27.06

22.26

26.92

27.17

55

11.52

FCF margin%

14.25

13.66

14.62

16.25

15.36

13.40

11.84

14.57

17.08

14.99

3.05

14.57

14.60

16

0.323

FCF / Net incomex

1.426

1.316

1.390

1.266

1.238

1.075

1.176

1.239

1.116

0.957

1.782

1.116

1.239

58

14.18

ROIC%

16.00

17.04

16.27

16.05

18.55

17.30

18.68

19.95

21.31

24.19

27.28

19.95

17.92

17

12.68

Return on equity%

3.73

2.85

1.92

3.56

0.74

1.89

0.40

0.52

0.97

3.66

23.61

0.97

1.90

77

12.80

Return on assets%

14.68

13.54

15.46

17.91

15.31

16.23

15.53

14.21

14.41

12.97

11.91

14.41

14.99

15

—

EPS€

—

—

—

—

—

—

—

—

—

—

—

(2.96%)

(3.54%)

—

21.71

EPS growth%

14.33

17.08

19.88

19.92

18.17

20.75

18.08

20.41

23.41

25.46

5.26

20.75

19.90

62

—

Bookvalue per sh€

—

—

—

—

—

—

—

—

—

—

—

2.40%

5.80%

—

—

FCF per share€

—

—

—

—

—

—

—

—

—

—

—

1.57%

3.66%

—

—

Dividend per sh€

—

—

—

—

—

—

—

—

—

—

—

(0.08%)

1.81%

—

27.74

Div yield (avg)%

22.83

22.67

22.67

21.89

23.18

24.73

23.99

23.19

20.46

22.71

9.80

23.19

22.77

29

17.79

Payout ratio%

22.69

19.99

21.13

18.78

20.12

20.00

17.73

15.85

18.40

15.55

22.91

17.73

19.38

67

138.7

Shares (diluted)M

196.9

232.0

261.3

268.4

275.5

309.4

363.9

366.6

407.4

426.0

142.7

9.11%

9.03%

5

2.72

Buyback yield%

20.45

19.93

21.66

23.21

21.22

21.35

19.82

17.34

15.15

14.20

15.50

17.34

20.19

77

0.934

D/E ratiox

1.862

1.759

2.008

2.350

2.385

2.508

2.527

2.861

2.794

2.904

0.765

2.794

2.447

78

—

Enterprise value€M

0.042

0.043

0.046

0.050

0.054

0.055

0.058

0.064

0.067

0.078

—

7.45%

6.88%

61

0.032

LT debt€M

—

—

—

—

—

—

—

—

—

—

—

2.17%

1.13%

27

Peers (US$0.126M)

Cap (US$)

PE

1.256M

—

0.243M

—

Jaguar Health, Inc.

0.210M

—

CDT Equity Inc.

0.074M

—

Capital

TTM

5Y

10Y

Leveragex

14.80

(0.562)

(0.544)

EBIT/Intx

0.784

0.261

0.270

Own earn%

961.48

(40.52)

(42.20)

Sh yield%

30.46

40.53

43.55

Owners

Insiders/Inst%

11.00

88.73

Short interest%

3.48

SBC / revenue%

0.91

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

11

Op margin range%

10–14

$1 testx

—

Incr. ROIC%

5

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

€0.027M

3.01%

1.00×

Cost of revenue

€0.017M

2.86%

0.99×

Operating expenses

—

3.25%

1.02×